We investigated how amino acid changes within and outside the V3 loop of the envelope glycoprotein of human immunodeficiency virus type 1 influence the infectivity, host range, and syncytium-forming ability of the virus. Our studies show that on the genomic backgrounds of the human immunodeficiency virus type 1 strains SF2 and SF13, a reciprocal exchange of full-loop sequences does not alter the syncytium-forming ability of the viruses, indicating that a determinant(s) for this biological property maps outside the loop. However, specific amino acid substitutions, both within and outside the V3 loop, resulted in loss of infectivity, host range, and syncytium-forming potential of the virus. Furthermore, it appears that a functional interaction of the V3 loop with regions in the C2 domain of envelope gpl20 plays a role in determining these biological properties. Structural studies of mutant glycoproteins show that the mutations introduced affect the proper association of gpl20 with the transmembrane glycoprotein gp4l. Our results suggest that mutations that alter the structure of the V3 loop can affect the overall conformation of gpl20 and that, reciprocally, the structure of the V3 loop is influenced by the conformation of other regions of gpl20. Since the changes in the replicative potential, host range, and fusogenic ability of the mutant viruses correlate well with the changes in gpl20 conformation, as monitored by the association of gpl20 with gp4l, our results support a close relationship between envelope gpl20 structural conformation and the biological phenotype of the virus.
Human immunodeficiency virus type 1 (HIV-1) isolates display a high degree of biological heterogeneity in vitro. The viruses differ with respect to their replicative kinetics, susceptibility to serum neutralization, and ability to infect different cell types and to induce syncytia in the infected cells (for reviews, see references 4, 5, and 9). Some of these properties have been shown to correlate with pathogenicity of the virus in vivo (1, 6, 29) . To define the minimal amino acid changes that confer differential cellular tropism as well as replicative and cytopathic properties of HIV-1, recombinant viruses were generated between two HIV-1 strains, SF2
and SF13 (HIV-1sF5 and HIV-lsFl3), which were recovered over time from the same individual. These two isolates are highly related at the nucleotide and amino acid sequence levels, but they display distinct biological properties. Compared with HIV-1sF2 (the early isolate), HIV-lsFl3 (the late isolate) replicates faster and to higher titers in peripheral blood mononuclear cells (PBMCs) and several T-cell lines and is highly cytopathic (6, 7) . Our prior characterization of recombinant viruses generated between HIV-1sF2 and HIV-lSF13 showed that a 0.49-kb StuI-MstII fragment of env gpl20, encompassing the V3 loop, contained a major determinant(s) of host range and syncytium-forming ability of these HIV-1 isolates (7) . A comparison of the predicted amino acid sequences of HIV-1sF2 and HIV-1sFl3 reveals 10 amino acid differences within this region of gp120, 4 of which are located in the V3 hypervariable region.
The V3 loop of gpl20 does not seem to play an important * Corresponding author.
role in CD4 binding, since neither alteration in the V3 sequences (10, 11, 17, 23) nor V3-specific antibodies (19, 27) affect the attachment of gp120 to CD4. This region does, however, appear to be involved in the postbinding fusion process necessary for viral entry (11, 15, 23, 24) and helps determine cellular host range (8, 14, 26, 28, 33) . The exact mechanism by which the V3 loop mediates these events is presently unclear. However, recent data accumulated in several laboratories suggest that the V3 loop participates in a process involving envelope conformational change (20, 25, 35) that leads to postbinding fusion with the cell membrane (21) .
To examine the role of V3 loop sequences of HIV-lsF2 and HIV-lsF13 in viral infectivity, host range, and syncytiumforming ability, and the mechanism(s) by which amino acid changes within and outside the V3 loop affect these biological properties, mutant viruses were generated on the genetic backgrounds of HIV-1sF2 and HIV-lsFl3 by site-directed mutagenesis. The replicative ability, host range, and cytopathic potential of the mutant viruses in vitro were then determined. Furthermore, wild-type and mutant envelope glycoproteins were expressed in transient expression systems. The expression and processing of these envelope products, the association of gp120 with gp4l, and the ability to induce syncytia were examined. Effects of amino acid composition of the V3 loop on viral infectivity and syncytium-forming ability. The WT'~KGIHIGPGRAVYT
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WT KSIYIGPGRAFHT (32) and immunoprecipitation with a polyclonal goat anti-gpl20 antibody (Chiron Corp., Emeryville, Calif.).
Results for HIV-lSFl3 wild-type and mutant glycoproteins are presented in Fig. 1 .
At 24 h posttransfection, we observed comparable levels of gpl60 expression and processing in mutant-and wildtype-transfected cells with no gpl20 detected in the cell supernatant. The exceptions were cells transfected with Mu2, which expresses less gpl60 and gpl20, and those transfected with Mu6, in which the processing of the envelope gpl60 appeared to be slower. At 38 and 48 h posttransfection, decreasing amounts of cell-associated gpl20 were noted in cells transfected with HIV-1sFl3 Mu2, Mu3, and Mu6, concomitant with an increase in the amounts of gpl20 found in cell supernatants. Increasing amounts of gpl20 were also found in the supernatant of Mu7-transfected cells at these time points, but more cell-associated gpl20 was present than in Mu3-and Mu6-transfected cells. HIV-lsFl3 Mul, Mu4, and Mu5, in contrast, were expressed and processed at levels similar to that of the wild type at these time points, although more gpl20 was consistently found in the supernatant of Mu5-transfected cells.
When the syncytium-forming ability of mutant glycoproteins was assessed at 24, 38, or 48 h posttransfection by cocultivating transfected cells with Sup-Ti cells, the ability of Mu4 and Mu7 glycoproteins to form syncytia was found to be decreased compared with that of the envelope of the wild-type virus, whereas Mu2, Mu3, and Mu6 glycoproteins were unable to form syncytia (Fig. 2) . In contrast, Mul and Mu5 glycoproteins displayed full fusogenic capacity.
Conclusions. Our studies of HIV-1sF2 and HIV-lsFl3 mutant viruses reveal certain features of the envelope glycoprotein gpl20 that are important in determining the infectivity, host range, and syncytium-forming ability of HIV-1. We observed that although the V3 loop of gpl20 is involved in 1 (Table 2 ) and induces a moderate degree of syncytium formation (Fig. 2) . Therefore, in agreement with our findings with the Mul HIV-1sF2 and HIV-1SF13 V3 loop mutant viruses, an interplay of the V3 loop with other regions of envelope gpl20 is implicated. Similar observations have been reported by others (22, 34, 35) . In particular, a functional interaction of the V3 domain with the second conserved region of gpl20 has previously been reported by Willey et al. (34) to determine HIV-1 infectivity.
Whether the changes introduced in these other regions of gpl20 alter the structure or presentation of the V3 loop requires further investigation. Structural studies of mutant glycoproteins showed that the mutations introduced at positions 311, 319, and 282 (HIV-1SF13 Mu2, Mu3, and Mu6, respectively) ( Tables 1 and   2 ) alter the association of gpl20 with gp4l. Furthermore, these mutant glycoproteins are defective in their syncytiumforming ability (Fig. 2) . These observations indicate a close relationship between changes in gpl20 conformation and the biological phenotype of HIV-1. Nevertheless, the finding that Mu5 displayed properties identical to those of wild-type HIV-1sFl3 (Table 2 and Fig. 2 ) yet released more gp120 into the supernatant of transfected cells (Fig. 1) suggests that gp120 dissociation is indicative of a gross structural change in the envelope gp120 which can be easily monitored but which may not be related to other more subtle conformational changes that are critical for viral infectivity, host range, and syncytium-forming ability. This conclusion is in agreement with data reported by others regarding sCD4-induced shedding of gpl20 (2, 30) .
Amino acids 311, 319, and 282 are located away from the C-terminal and N-terminal domains of gpl20, regions that are reported to be involved in the association of gpl20 with gp4l (12, 16) . It is possible that either the V3 loop or the C2 domain is in close proximity with either the C terminus or the N terminus of native gpl20 and that aberrant V3 or C2 conformations affect the Cl and CS regions of gpl20. Alternatively, the changes in the structures of the V3 and C2 regions can be transmitted to and affect the conformation of other portions of the envelope gpl20, e.g., the C4 domain, which has been implicated to have a structural relationship to the V3 loop (35) and has also been shown to modulate the interaction of gpl20 and gp4l (12) .
In conclusion, we have shown that the V3 loop of envelope gpl20 by itself does not regulate the entry of the virus into target cells and does not control the syncytium-forming ability of the HIV-1 isolates studied here. Our data suggest that the amino acid composition within the V3 loop determines the overall structure and/or presentation of the loop. An interplay between several regions of the envelope glycoprotein, including the V3 loop, determines the gpl20 structural conformation. The conformation of gp120, in turn, may define the extent and type of postbinding structural changes that lead to viral entry. Changes in one region of gpl20 can affect the functions of other regions of the viral envelope. Therefore, the biologic phenotype of a particular viral isolate appears to be determined by the overall conformation of its envelope glycoprotein and not by the structure or sequence of a particular region.
We thank Jay Levy for valuable comments, Oanh Nguyen for technical assistance, and Ann Murai for preparation of the manuscript. 
